The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study
Nutrients · 31.01.2025 · 17 (3) · 564
DOI: 10.3390/nu17030564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 31.01.2025. Verfasst von Li Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, USA. Hauptthemen laut MEDLINE: Topiramate, Glucose, Flavonoids, Fatty Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, UCLA Clinical and Translational Science Institute, University of California Los Angeles Clinical and Translational Science Institute, NIH NCATS.
Abstract (Originalsprache)
Background
Insufficient treatment options are available for metabolic dysfunction-associated steatotic liver disease (MASLD). Flavonoids and topiramate have been studied for weight loss but need investigation into their effects on liver metabolism. This study’s aim was to examine the effects of flavonoids or topiramate on glucose metabolic carbon flux in a cell culture model of steatosis.
Methods
Steatosis was induced in HepG2 cells through exposure to oleic acid (OA, 0.5 mml/L) conjugated to bovine serum albumin (2:1). Additionally, 50% U13C-glucose was supplied in the medium as a stable isotope tracer. Cells were treated with DMSO, 10 μM of naringenin, morin, silibinin, or topiramate (44 μM) for 72 h. A non-steatotic, untreated HepG2 cell control was included. Cell extracts were analyzed by gas chromatography/mass spectrometry and mass isotopomer distribution analysis for glycogen synthesis, de novo fatty acid synthesis, tricarboxylic acid (TCA) cycle activity, and ribose synthesis. Groups were compared by ANOVA with Tukey’s pair-wise testing.
Results
Compared to untreated HepG2 controls, OA-exposed steatotic cells exhibited increased lipid accumulation by ORO staining (1.6-fold), enhanced palmitate de novo synthesis, reduced pyruvate carboxylase/pyruvate dehydrogenase (PC/PDH) ratio, and reduced ribose synthesis. Treatment with topiramate or silibinin ameliorated the lipid accumulation (1.3-fold) and mitigated enhancement of de novo synthesis. Morin-treated cells exhibited enhanced de novo synthesis but suppressed ribose synthesis.
Conclusions
Potential mechanisms of reduced lipid accumulation by topiramate and silibinin may include suppression of palmitate de novo synthesis and a relative decrease in carbon flux through the PDH pathway. Further studies are needed on potential utility in MASLD based on their specific metabolic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, USA.
- Jiangsu Key Laboratory for the Research and Utilization of Plant Resources, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences (Nanjing Botanical Garden Memorial Sun Yat-Sen), No. 1 Qianhuhoucun Villa…
- Center for Human Nutrition, Department of Medicine, and Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
- Medicine and Health Care Division, Hungarian Society of Natural Sciences, Jászai Mari Square 4/a, Floor/Door 1/1, H-1137 Budapest, Hungary.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
- Department of Pediatrics, David Geffen School of Medicine at the University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
ORCID-Profile: Qing-Yi Lu, Laszlo G Boros, Jennifer K Yee
Förderung
- NCATS NIH HHS
- UCLA Clinical and Translational Science Institute
- University of California Los Angeles Clinical and Translational Science Institute, NIH NCATS
Zitieren
APA
Ma, L., Lu, Q. Y., Lim, S., Han, G., Boros, L. G., Desai, M., & Yee, J. K. (2025). The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study. Nutrients, 17(3), 564. https://doi.org/10.3390/nu17030564
Vancouver
Ma L, Lu QY, Lim S, Han G, Boros LG, Desai M, et al. The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study. Nutrients. 2025;17(3):564. doi:10.3390/nu17030564
BibTeX
@article{Ma2025,
author = {Ma, Li and Lu, Qing-Yi and Lim, Shu and Han, Guang and Boros, Laszlo G and Desai, Mina and Yee, Jennifer K},
title = {The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {3},
pages = {564},
doi = {10.3390/nu17030564}
}
EUVIMED